Effect of Tislelizumab Combined with Docetaxel Second-line Treatment on Short-term Efficacy and Tumor Markers in Patients with Advanced Non-small Cell Lung Cancer

CHEN Xi, GUO Jiaxun, GONG Jun, CHEN Jia, SU Xiaoqin

PDF(1013 KB)
PDF(1013 KB)
Chinese And Foreign Medical Research ›› 2025, Vol. 23 ›› Issue (14) : 9-12. DOI: 10.14033/j.cnki.cfmr.2025.14.003
Article

Effect of Tislelizumab Combined with Docetaxel Second-line Treatment on Short-term Efficacy and Tumor Markers in Patients with Advanced Non-small Cell Lung Cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 23(14): 9-12 https://doi.org/10.14033/j.cnki.cfmr.2025.14.003

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1013 KB)

Accesses

Citation

Detail
Sections
Recommended

  • Copyright © Chinese And Foreign Medical Research

    Supported by:Beijing Magtech

    京ICP备20023298号

/

〈 〉